Paulson & Co. Inc. John Paulson
Jersey City, NJ 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $2.6B
- 8 holdings
- 2026 Q2
- −17.2% QoQ
- Top 5 92.3%
AUM over time
Book
| Horizon Therapeutics Pub | Add +320.6% | 2,103,046 | $115.69 | $243M | +1,603,046 | +$192M | |
| BHC, Bausch Health Companies | Hold | 26,439,035 | $8.22 | $217M | — | — | |
| AAMI, Brightsphere Investment Group | Hold | 8,950,121 | $19.39 | $174M | — | — | |
| NG, Novagold Resources | Hold | 22,226,300 | $3.84 | $85M | — | — | |
| PPTA, Perpetua Resources | Hold | 24,771,542 | $3.26 | $81M | — | — | |
| MDGL, Madrigal Pharmaceuticals | Add +42.8% | 500,000 | $146.04 | $73M | +149,800 | −$7.9M | |
| AU, Anglogold Ashanti | New | 3,833,492 | $15.80 | $61M | +3,833,492 | +$61M | |
| THRY, Thryv | Hold | 2,000,000 | $18.77 | $38M | — | — | |
| AEM, Agnico Eagle Mines | Hold | 783,561 | $45.45 | $36M | — | — | |
| SSR Mining In | Hold | 2,000,000 | $13.29 | $27M | — | — | |
| SA, Seabridge Gold | Hold | 2,070,000 | $10.55 | $22M | — | — | |
| THM | Hold | 61,930,724 | $0.3520 | $22M | — | — | |
| EQX, Equinox Gold | Hold | 2,500,000 | $4.23 | $11M | — | — | |
| Newmark Group | Hold | 1,284,625 | $6.43 | $8.3M | — | — | |
| Trilogy Metals | Hold | 14,326,996 | $0.4900 | $7M | — | — | |
| Tellurian | Hold | 5,340,663 | $1.16 | $6.2M | — | — | |
| BABA, Alibaba | Hold | 50,000 | $86.74 | $4.3M | — | — | |
| Iamgold | Hold | 1,850,000 | $2.15 | $4M | — | — |
Exits / last held
Gone since 2023 Q2, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| AU, Anglogold Ashanti | Exit | 0 | $21.09 | $81M | −3,833,492 | −$81M | |
| NEM, Newmont | Exit | 0 | $42.66 | $19M | −452,000 | −$19M | |
| Iveric Bio | Exit | 0 | $39.36 | $984K | −25,000 | −$984K | |
| Diversey | Exit | 0 | $8.40 | $420K | −50,000 | −$420K |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 8 | $2.6B | −17.2% | 13F-HR | 8/14/2026 | 000101359426000913 |
| 2026 Q1 | 9 | $3.1B | −4.6% | 13F-HR | 5/15/2026 | 000101359426000611 |
| 2025 Q4 | 9 | $3.3B | +9.9% | 13F-HR | 2/17/2026 | 000101359426000257 |
| 2025 Q3 | 10 | $3B | +47.6% | 13F-HR | 11/14/2025 | 000101359425001436 |
| 2025 Q2 | 15 | $2B | +15.1% | 13F-HR | 8/14/2025 | 000101359425001044 |
| 2025 Q1 | 14 | $1.7B | +5.8% | 13F-HR | 5/15/2025 | 000101359425000679 |
| 2024 Q4 | 13 | $1.7B | +15.9% | 13F-HR | 2/14/2025 | 000101359425000309 |
| 2024 Q3 | 15 | $1.4B | +5.3% | 13F-HR | 11/14/2024 | 000101359424000980 |
| 2024 Q2 | 16 | $1.4B | −6.6% | 13F-HR | 8/14/2024 | 000101359424000667 |
| 2024 Q1 | 18 | $1.4B | +30.7% | 13F-HR | 5/15/2024 | 000101359424000487 |
| 2023 Q4 | 17 | $1.1B | −0.9% | 13F-HR | 2/14/2024 | 000101359424000197 |
| 2023 Q3 | 18 | $1.1B | +9.2% | 13F-HR | 11/14/2023 | 000101359423000930 |
| 2023 Q2 | 21 | $1B | −14.9% | 13F-HR | 8/14/2023 | 000101359423000696 |
| 2023 Q1 | 20 | $1.2B | +8.3% | 13F-HR | 5/15/2023 | 000101359423000494 |
| 2022 Q4 | 22 | $1.1B | −18.7% | 13F-HR | 2/14/2023 | 000101359423000262 |
| 2022 Q3 | 28 | $1.4B | −32.6% | 13F-HR | 11/14/2022 | 000156761922020074 |
| 2022 Q2 | 32 | $2B | −37.6% | 13F-HR | 8/15/2022 | 000156761922016238 |
| 2022 Q1 | 33 | $3.2B | +0.2% | 13F-HR | 5/16/2022 | 000156761922011018 |
| 2021 Q4 | 36 | $3.2B | −7.6% | 13F-HR | 2/14/2022 | 000156761922004409 |
| 2021 Q3 | 38 | $3.5B | — | 13F-HR | 11/15/2021 | 000156761921020479 |
About
Paulson & Co. Inc.
20 processed 13Fs on this site, 2021 Q3 to 2026 Q2